Home Cart Sign in  
Chemical Structure| 1799974-70-1 Chemical Structure| 1799974-70-1
Chemical Structure| 1799974-70-1
Product Citations

Alternative Products

Product Details of KI696

CAS No. :1799974-70-1
Formula : C28H30N4O6S
M.W : 550.63
SMILES Code : O=C(O)C[C@@H](C1=CC=C(C)C(CN(C[C@@H](C)OC2=CC=CC=C23)S3(=O)=O)=C1)C4=CC(OC)=C(N(C)N=N5)C5=C4
Synonyms :
KI696
MDL No. :MFCD31630709
InChI Key :ZDNGJXBUEQNFBQ-GCJKJVERSA-N
Pubchem ID :118170767

Safety of KI696

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description Reference
KP cells 1 µM 36 hr To validate that treatment with KI696 could increase Nrf2 protein levels as well as increase expression of downstream target genes in KP cells, and induce sensitivity to CB-839. PMC5624783
H2009 cells 1 µM 36 hr To validate that treatment with KI696 could increase NRF2 protein levels as well as increase expression of downstream target genes in H2009 cells, and induce sensitivity to CB-839. PMC5624783
KP cells 1 μM 96 h To evaluate the effect of KI696 on the sensitivity of KP cells to PARP inhibitors PMC8751279
non-small cell lung cancer cell lines 1 μM 48 h To investigate the effect of KI696 on the proliferation of non-small cell lung cancer cell lines, it was found that KI696 significantly inhibited proliferation in some cell lines PMC9998367
HEK293T cells 5 μM 24 h KI696 treatment restored DPP9 activity, indicating that KEAP1 binding was responsible for DPP9 inhibition. PMC11773481
mouse KrasG12D/+; p53−/− lung adenocarcinoma cells 1μM 3 days To evaluate the growth inhibitory effect of KI696 on cells under serine or asparagine deprivation, results showed that KI696 treatment significantly inhibited cell growth. PMC7004873
mouse KrasG12D/+; p53+/+ lung adenocarcinoma cells 1μM 3 days To evaluate the growth inhibitory effect of KI696 on cells under serine or asparagine deprivation, results showed that KI696 treatment significantly inhibited cell growth. PMC7004873
mouse KrasG12D/+; p53−/− pancreatic cancer cells 1μM 3 days To evaluate the growth inhibitory effect of KI696 on cells under serine deprivation, results showed that KI696 treatment significantly inhibited cell growth. PMC7004873
non-small cell lung cancer cell lines 1 μM 48 h To evaluate the effect of KI696 on cell proliferation, it was found that more than 13% of the cell lines showed significant inhibition of proliferation after KI696 treatment PMC9998367

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description Reference
mice C57BL/6J mice intraperitoneal injection 0.66 mg/kg once a day for 15 days To evaluate the therapeutic effect of PARP inhibitors on KEAP1-mutant tumors PMC8751279
mice patient-derived xenograft model (PDX) oral gavage 5 mg/kg 3 times a week for 3 weeks To investigate the inhibitory effect of IACS-010759 on KEAP1-mutant tumors, it was found that IACS-010759 significantly inhibited the growth of KEAP1-mutant tumors PMC9998367
mice patient-derived xenograft (PDX) model oral 5 mg/kg 3 times a week for a total of 3 weeks To evaluate the growth inhibitory effect of IACS-010759 on KEAP1-mutant tumors, it was found that IACS-010759 significantly inhibited the growth of KEAP1-mutant tumors PMC9998367

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

1.82mL

0.36mL

0.18mL

9.08mL

1.82mL

0.91mL

18.16mL

3.63mL

1.82mL

 

Historical Records

Categories